Lunai Bioworks Inc. (LNAI) Stock
Lunai Bioworks stock price chart
LNAI stock quote & key statistics
Lunai Bioworks annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2026 | $51,992 | -$3.56B | — |
| FY2025 | $0 | -$178.0M | -$29.34 |
| FY2024 | $0 | -$88.4M | -$71.95 |
| FY2023 | $0 | -$39.7M | -$42.09 |
| FY2022 | $0 | -$113.4M | -$136.64 |
Fiscal year ending June 30. Source: company filings via EODHD.
About Lunai Bioworks Inc.
Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States, Canada, and the Netherlands. It operates through two segments, RENB and BioSymetrics. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer.
It also develops BioSymetrics platform, for multi-omics integration for target identification and validation; clinical trial optimization, including patient stratification and response monitoring; and screening of gene and small molecule effects for the purpose of identifying novel drug targets and therapeutics. The company was formerly known as Renovaro Inc. and changed its name to Lunai Bioworks Inc. in August 2025. Lunai Bioworks Inc. is based in Sacramento, California.
Lunai Bioworks stock FAQ
What is the Lunai Bioworks stock ticker symbol?
Lunai Bioworks Inc. trades on the NASDAQ under the ticker symbol LNAI.
What sector and industry is Lunai Bioworks in?
Lunai Bioworks Inc. is classified in the Healthcare sector, Biotechnology industry.
How many employees does Lunai Bioworks have?
Lunai Bioworks Inc. has about 12 full-time employees.
What were Lunai Bioworks's revenue and earnings last fiscal year?
Lunai Bioworks reported revenue of $51,992 and net income of -$3.56B in fiscal 2026.
When did Lunai Bioworks go public?
Lunai Bioworks stock began trading on February 2, 2015.
Biotechnology stocks
All Healthcare stocks →- ACADACADIA Pharmaceuticals
- ALNYAlnylam
- ARWRArrowhead Pharmaceuticals
- ASNDAscendis Pharma A/S
- BMRNBioMarin Pharmaceutical
- CAICaris Life Sciences
- CORTCorcept Therapeutics
- EXELExelixis
- FTREFortrea
- HALOHalozyme Therapeutics
- HRMYHarmony Biosciences
- INCYIncyte
- IONSIonis Pharmaceuticals
- JAZZJazz Pharmaceuticals
- MDGLMadrigal Pharmaceuticals
- MRNAModerna
- NVAXNovavax
- PTCTPTC Therapeutics
- RAREUltragenyx Pharmaceutical
- REGNRegeneron
- RPRXRoyalty Pharma
- SRPTSarepta Therapeutics
- TECHBio-Techne
- VRTXVertex